Mark Wotkowicz
About Mark Wotkowicz
Mark Wotkowicz is a Quality Assurance Manager at Bristol Myers Squibb with a background in pharmaceutical sciences and biology.
Current Role at Bristol Myers Squibb
Mark Wotkowicz serves as a Quality Assurance Manager at Bristol Myers Squibb in the United States. In this role, he is responsible for ensuring that the product quality meets regulatory requirements and company standards. His extensive background in the pharmaceutical industry plays a crucial role in overseeing quality systems and compliance within the organization.
Previous Positions at Bristol Myers Squibb
Before his current role, Mark Wotkowicz worked at Bristol Myers Squibb as a QC Investigation Lead from 2020 to 2021. Based in Devens, Massachusetts, he oversaw quality control investigations, ensuring compliance with cGMP regulations. His responsibilities included identifying root causes of deviations and implementing corrective actions to maintain product quality.
Experience at Regeneron
From 2017 to 2020, Mark Wotkowicz was a Biotech Production Compliance Coordinator III at Regeneron in Rensselaer, New York. During his three-year tenure, he coordinated compliance activities for biotech production, ensuring adherence to regulatory standards. His role involved managing and resolving compliance issues, contributing to the effectiveness of production processes.
Educational Background
Mark Wotkowicz holds a Master's degree in Pharmaceutical Sciences from the University of Florida, which he obtained between 2013 and 2015. Prior to that, he earned a Bachelor's degree in Biology from Northeastern University, completing his studies from 1999 to 2003. His educational background provided a strong foundation for his career in the pharmaceutical and biotech industries.
Technical Expertise and Professional Evolution
Mark Wotkowicz has a diversified technical background with years of experience in drug screening and protein production and purification. He transitioned from a bench scientist role in R&D to a deviations investigator in cGMP-regulated biologics manufacturing facilities. His expertise in these areas has made significant contributions to the quality and compliance sectors within the pharmaceutical industry.